Alpha Arbutin vs Kojic Acid
Which is right for your skin?
Both fade dark spots by slowing melanin production. Alpha arbutin is the gentle, long-haul option built for sensitive skin and daily use; kojic acid is the more potent brightener for stubborn pigment but is likelier to irritate. Sensitive skin → arbutin; stubborn spots → kojic.
A safer, slower-acting alternative to prescription-strength dark-spot faders. Built for long-term use without irritation.
A brightening ingredient derived from fungi that fades dark spots and evens skin tone.
Can you use Alpha Arbutin and Kojic Acid together?
We have no documented layering conflict between Alpha Arbutin and Kojic Acid. Introduce one at a time and patch-test.
You want brightening. A safer, slower-acting alternative to prescription-strength dark-spot faders. Built for long-term use without irritation.
You want brightening. A brightening ingredient derived from fungi that fades dark spots and evens skin tone.
Cited research
Ma ZY, Lu Y, Melanin synthesis and regulation in vivo and commonly used melanin inhibitors from natural products and traditional Chinese medicine, Zhongguo Zhong Yao Za Zhi (China Journal of Chinese Materia Medica) 2020;45(24):5898-5916 — Beijing University of Chinese Medicine review classifies arbutin among tyrosinase-active-site-targeting melanin inhibitors
Morag M et al., A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations, Journal of Cosmetic Dermatology 2015 — 76% of melasma patients showed clinical lightening over 8 weeks
Kim H, Choi HR, Kim DS, Park KC, Topical hypopigmenting agents for pigmentary disorders and their mechanisms of action, Annals of Dermatology 2012;24(1):1-6 — review classifies arbutin among hypopigmenting agents via tyrosinase regulation as a hydroquinone alternative
Seo DH et al., Biotechnological production of arbutins (alpha- and beta-arbutins), skin-lightening agents, and their derivatives, Applied Microbiology and Biotechnology 2012;95(6):1417-1425 — review documenting arbutin glycosylated hydroquinones as competitive tyrosinase inhibitors producing skin-whitening effect with improved safety vs hydroquinone
Ertam I et al., Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study, Journal of Dermatology 2008 — arbutin (and ellagic acid) formulations effectively reduced melasma severity
Chang YF et al., Efficacy and safety of topical agents in the treatment of melasma: a network meta-analysis, Journal of Cosmetic Dermatology 2023;22(4):1168-1176 — MA finding kojic acid comparably effective with low irritation for melasma
Park JH et al., Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial, Dermatologic Therapy 2022;35(3):e15287 — laser-assisted delivery of TXA/niacinamide/kojic acid produced greater melasma improvement vs laser alone
Scientific Committee on Consumer Safety (SCCS). Opinion on Kojic Acid (CAS No. 501-30-4). SCCS/1637/21. Preliminary opinion October 26-27, 2021; Final opinion adopted March 15-16, 2022; Corrigendum August 2023. Concludes kojic acid is safe as a skin lightening agent in cosmetic products at concentrations up to 1%, with caveats regarding peeling agent combinations and endocrine disruption concerns.
Austin E et al., Topical Treatments for Melasma: A Systematic Review of Randomized Controlled Trials, Journal of Drugs in Dermatology 2019;18(11):1156-1171 — SR of topical melasma RCTs evaluating kojic acid among agents
Hollinger JC et al., Are Natural Ingredients Effective in the Management of Hyperpigmentation? A Systematic Review, Journal of Clinical and Aesthetic Dermatology 2018;11(2):28-37 — SR of natural depigmenting ingredients including kojic acid
Singh BK et al., Kojic Acid Peptide: A New Compound with Anti-Tyrosinase Potential, Annals of Dermatology 2016;28(5):555-561 — kojic acid peptide inhibits tyrosinase and reduces melanin without cytotoxicity, addressing the instability/toxicity limits of native kojic acid
Deo KS et al., Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: a randomized, single blind, comparative study of efficacy and safety, Indian Journal of Dermatology 2013;58(4):281-5 — kojic acid + hydroquinone superior depigmenting agent over 12 weeks
Lim JT, Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid, Dermatologic Surgery 1999;25(4):282-284 — split-face trial isolating the added benefit of 2% kojic acid for melasma
Every entry points to a specific paper or regulatory document. See methodology for what each outcome label means.